封面
市場調查報告書
商品編碼
2051024

藥物輸送裝置市場:依給藥途徑、應用、最終用戶及地區分類

Drug Delivery Device Market, By Route of Administration, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,藥物輸送裝置市場規模將達到2,502.2億美元,到2033年將達到4,633.2億美元。預計從2026年到2033年,該市場將以9.2%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2502.2億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.20% 2033年市場規模預測: 4633.2億美元

藥物輸送裝置是指用於在體內輸送藥物化合物的各種技術。有效的藥物傳遞可確保活性成分在作用部位達到適當的濃度,進而提高藥物療效和病人的用藥依從性。生物製藥和個人化醫療的快速發展,以及慢性病盛行率的不斷上升,有望推動先進藥物輸送系統的需求。藥物輸送裝置的持續創新,尤其是在提高安全性、精確性和易用性方面,將在不久的將來推動市場成長。

市場動態

全球藥物傳輸裝置市場的成長主要受糖尿病、癌症和心血管疾病等慢性病盛行率上升的驅動。老年人口的成長和醫療保健成本的上漲也促進了市場成長。然而,開發先進輸送系統的高成本可能會阻礙市場成長。創新產品的監管障礙也可能成為限制因素。新興市場為市場相關人員提供了極具吸引力的機會。對自行注射裝置和居家醫療日益成長的需求可能創造市場成長機會。攜帶式和穿戴式給藥系統的持續技術進步也將帶來成長機會。物聯網(IoT)智慧型裝置的應用是市場的一大趨勢。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球藥物輸送設備市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球藥物輸送設備市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 透過分析全球藥物輸送設備市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球藥物輸送裝置市場:依給藥途徑分類,2021-2033年

  • 口服
  • 腸外
  • 經皮
  • 眼科

第5章 全球藥物輸送裝置市場:依應用領域分類,2021-2033年

  • 腫瘤學
  • 感染疾病
  • 呼吸系統疾病
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 中樞神經系統疾病

第6章 全球藥物傳輸設備市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷中心
  • 門診手術中心/診所
  • 居家醫療
  • 其他

第7章 全球藥物輸送設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • Abbott Laboratories
  • Adherium Ltd.
  • Amiko Digital Health Limited
  • Becton, Dickinson and Company
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5419

Drug Delivery Device Market is estimated to be valued at USD 250.22 Bn in 2026 and is expected to reach USD 463.32 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 250.22 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.20% 2033 Value Projection: USD 463.32 Bn

Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.

Market Dynamics

Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global drug delivery device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market.

Market Segmentation

  • By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
  • Oral
  • Parenteral
  • Transdermal
  • Ocular
  • Pulmonary
  • By Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • By End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others
  • By Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Abbott Laboratories
  • Adherium Ltd.
  • Amiko Digital Health Limited
  • Becton, Dickinson and Company
  • BIOCORP
  • CeQur Corporation
  • Cognita Labs
  • E3D Elcam Drug Delivery Devices
  • H&T Presspart Manufacturing Ltd.
  • HCmed Innovations Co., Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Phillips-Medisize
  • Sonceboz
  • Enable Injections, Inc.
  • NOVO Engineering
  • Elcam Medical
  • Battelle
  • Gerresheimer AG
  • Aphios

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Drug Delivery Device Market, By Route of Administration
    • Global Drug Delivery Device Market, By Application
    • Global Drug Delivery Device Market, By End User
    • Global Drug Delivery Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Drug Delivery Device Market, By Route of Administration, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ocular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Drug Delivery Device Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Central Nervous System Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Drug Delivery Device Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgery Centers/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Drug Delivery Device Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country/Sub-region, 2021 - 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Adherium Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amiko Digital Health Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BIOCORP
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CeQur Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cognita Labs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • E3D Elcam Drug Delivery Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • H&T Presspart Manufacturing Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HCmed Innovations Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phillips-Medisize
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sonceboz
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Enable Injections, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NOVO Engineering
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elcam Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Battelle
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gerresheimer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aphios
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us